mesothelioma    
Complete Mesothelioma Information for Patients and their Families
> Mesothelioma
> Mesothelioma Information
   Pleural Mesothelioma
   Peritoneal Mesothelioma
   Mesothelioma Symptoms
   Malignant Mesothelioma
   Diagnosis
   Staging

> Treatment Options
   Medical Procedures
   Drugs / Medications

   
Alimta Info
   Find a Doctor
   Clinical Trials
   Hospitals
   Support
> Coping Strategy
   What to Do
   Financial Recovery
   Who Can Help
   Mesothelioma Asbestos
    Lawyer Information

> What Caused Mesothelioma
   Possible places of Asbestos
   Exposure - Where was I
   Exposed
   Information about
   Asbestos & FAQs
   Hazardous Jobs
> Articles & News
   News
   Articles on Asbestos
   Articles on Treatment
    Options
> Click Here For A Free
    Information Packet
> Contact Us
> Sponsorship Info &
   Disclaimer
> Order Brochure


FOR MORE INFORMATION
Please call 1-800-362-1479.
We will gladly answer your
questions and send a free
booklet with additional
information on:
  • New treatment options
  • New medications
  • Doctor locations
  • Legal Issues
  • Clinical Trials
  • Financial Assistance

 
 
Treatment Options
 
Drugs / Medications I Alimta I Trial Details I Alimta vs. Taxotere I Side Effects

Drugs / Medications

What follows is a list of mesothelioma medications. Please contact us directly for the most updated mesothelioma drug information.

ALIMTA [ (pemetrexed) is now available on expanded access basis. ALIMTA will be available on an expanded access use for people with malignant pleural mesothelioma, a cancer usually associated with exposure to asbestos. As of July 9, 2002 the Food and Drug Administration agreed to place ALIMTA in an expanded access program, which gives patients access to an agent that isn't yet commercially available, although the sponsor is actively pursuing marketing approval. Eli Lilly is pursuing approval of ALIMTA in combination with cisplatin for the treatment of malignant pleural mesothelioma, a disease that causes tumors to grow in the linings of the lung, or pleura. Patients live an average of six to nine months following diagnosis. The company said results of a Phase III trial showed that patients treated with ALIMTA and cisplatin combined lived longer and had less pain and shortness of breath, than patients treated with cisplatin alone. In the trial, the most common side effect from cisplatin and ALIMTA was a decrease in infection- fighting white blood cells. Under the expanded access program, ALIMTA will be given free of charge to patients who meet medical eligibility requirements.

Click here for detailed Alimta Information


L-NDDP (aroplatin). Intrapleural administration is intended to exceed the usefulness of other platinum drugs like Cisplatin that are limited by toxicity and drug resistance.

Endostatin. Has been shown to inhibit a tumor's ability to grow blood vessels without destroying normal healthy cells. Works with angiostatin. Lovastatin. A cholesterol drug shown to potentially inhibit the growth of cancer cells.

Intrapleural interferon gamma. The anti-cancer drug, Interferon Gamma is directly administered into the affected area.

Photodynamic therapy. Light energy is used to destroy cancer cells. Immunotherapy. Focuses on strengthening the immune system to assist the body in fighting the disease.

Gene Therapy. Focuses on pinpointing and correcting the genetic defect that first allowed the tumor to develop.

Drugs / Medications I Alimta I Trial Details I Alimta vs. Taxotere I Side Effects

To learn more about new mesothelioma medications and clinical trials call for a free information package 1-800-362-1479 or email us below.

CLICK HERE to Request a FREE Information Package which includes Treatment Options and Financial Assistance Info.


 
       
Please mail me a FREE Information Package / Make a Request
(Package include Treatment Options & Financial Assistance Info)

Name:      
Street 1:      
Street 2:      
City:      
State:   Zip:  
Tel:      
Email:      
Requests:  
Or Call Toll Free 1-800-362-1479